NVCR Q4 2020 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$144M+45.1% YoY

Gross Profit

$116M80.5% margin

Operating Income

$12M8.4% margin

Net Income

$5M3.4% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+8.5%

Cash Flow

Operating Cash Flow

$53M

Free Cash Flow

$48M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$575M

Stockholders' Equity

$477M

Cash & Equivalents

$246M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$144M	$99M	+45.1%
Gross Profit	$116M	$74M	+55.6%
Operating Income	$12M	$152,000	+7855.3%
Net Income	$5M	$4M	+15.4%

Geographic Segments

UNITED STATES

$98M71%

GERMANY

$27M20%

JAPAN

$8M6%

CHINA

$5M3%